Literature DB >> 24025452

Analytical accuracy and user-friendliness of the Afinion point-of-care CRP test.

Jan Y Verbakel1, Bert Aertgeerts, Marieke Lemiengre, An De Sutter, Dominique M A Bullens, Frank Buntinx.   

Abstract

Entities:  

Keywords:  Diagnosis; Infections; Paediatric Pathology; Poc Testing

Mesh：

Substances：

Year:  2013        PMID： 24025452     DOI： 10.1136/jclinpath-2013-201654

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  10 in total

1.  Reducing inappropriate antibiotic prescribing for children in primary care: a cluster randomised controlled trial of two interventions.

Authors:  Marieke B Lemiengre; Jan Y Verbakel; Roos Colman; Tine De Burghgraeve; Frank Buntinx; Bert Aertgeerts; Frans De Baets; An De Sutter
Journal:  Br J Gen Pract       Date:  2018-02-12       Impact factor: 5.386

2.  Accuracy and feasibility of point-of-care white blood cell count and C-reactive protein measurements at the pediatric emergency department.

Authors:  Lauri Ivaska; Jussi Niemelä; Pia Leino; Jussi Mertsola; Ville Peltola
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.240

3.  Diagnosing serious infections in acutely ill children in ambulatory care (ERNIE 2 study protocol, part A): diagnostic accuracy of a clinical decision tree and added value of a point-of-care C-reactive protein test and oxygen saturation.

Authors:  Jan Y Verbakel; Marieke B Lemiengre; Tine De Burghgraeve; An De Sutter; Dominique M A Bullens; Bert Aertgeerts; Frank Buntinx
Journal:  BMC Pediatr       Date:  2014-10-02       Impact factor: 2.125

4.  Should all acutely ill children in primary care be tested with point-of-care CRP: a cluster randomised trial.

Authors:  Jan Y Verbakel; Marieke B Lemiengre; Tine De Burghgraeve; An De Sutter; Bert Aertgeerts; Bethany Shinkins; Rafael Perera; David Mant; Ann Van den Bruel; Frank Buntinx
Journal:  BMC Med       Date:  2016-10-06       Impact factor: 8.775

5.  Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial.

Authors:  Marjolein Jc Schot; Ann Van den Bruel; Berna Dl Broekhuizen; Jochen Wl Cals; Eveline A Noteboom; Walter Balemans; Rogier M Hopstaken; Sanne van Delft; Niek J de Wit; Theo Jm Verheij
Journal:  BJGP Open       Date:  2018-07-11

6.  Antibiotic prescribing rate after optimal near-patient C-reactive protein testing in acutely ill children presenting to ambulatory care (ARON project): protocol for a cluster-randomized pragmatic trial.

Authors:  Jan Yvan Jos Verbakel; Tine De Burghgraeve; Ann Van den Bruel; Samuel Coenen; Sibyl Anthierens; Louise Joly; Annouschka Laenen; Jeroen Luyten; An De Sutter
Journal:  BMJ Open       Date:  2022-01-03       Impact factor: 2.692

7.  Performance and ease of use of a molecular point-of-care test for influenza A/B and RSV in patients presenting to primary care.

Authors:  Jan Y Verbakel; Veerle Matheeussen; Katherine Loens; Mandy Kuijstermans; Herman Goossens; Margareta Ieven; Christopher C Butler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-03-14       Impact factor: 3.267

8.  Point-of-care CRP matters: normal CRP levels reduce immediate antibiotic prescribing for acutely ill children in primary care: a cluster randomized controlled trial.

Authors:  Marieke B Lemiengre; Jan Y Verbakel; Roos Colman; Kaatje Van Roy; Tine De Burghgraeve; Frank Buntinx; Bert Aertgeerts; Frans De Baets; An De Sutter
Journal:  Scand J Prim Health Care       Date:  2018-10-25       Impact factor: 2.581

9.  Evaluation of Point-of-Care Testing for C-Reactive Protein in Forensic Medicine.

Authors:  Joo Young Na; Jong Tae Park
Journal:  J Korean Med Sci       Date:  2019-10-07       Impact factor: 2.153

10.  Impact of point-of-care panel tests in ambulatory care: a systematic review and meta-analysis.

Authors:  Clare Goyder; Pui San Tan; Jan Verbakel; Thanusha Ananthakumar; Joseph J Lee; Gail Hayward; Philip J Turner; Ann Van Den Bruel
Journal:  BMJ Open       Date:  2020-02-27       Impact factor: 2.692
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.